The PE Ratio as of June 2026 (TTM) for Generex Biotechnology Corporation (GNBT) is -0.00

According to Generex Biotechnology Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -99.93% compared to the average of -2.47 of the last 4 quarters.

Generex Biotechnology Corporation (GNBT) Historical PE Ratio (quarterly & annually)

How has GNBT PE Ratio performed in the past?

The mean historical PE Ratio of Generex Biotechnology Corporation over the last ten years is -430.58. The current -0.00 PE Ratio has changed -99.96% with respect to the historical average. Over the past ten years (40 quarters), GNBT's PE Ratio was at its highest in in the October 2014 quarter at 35.24. The PE Ratio was at its lowest in in the January 2016 quarter at -41.17.

Generex Biotechnology Corporation (GNBT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Generex Biotechnology Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Generex Biotechnology Corporation (GNBT) Average PE Ratio

How has GNBT PE Ratio performed in the past?

The current PE Ratio of Generex Biotechnology Corporation (GNBT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Generex Biotechnology Corporation (GNBT) PE Ratio vs. Peers

How is GNBT’s PE Ratio compared to its peers?

Generex Biotechnology Corporation’s PE Ratio is less than Predictive Technology Group, Inc. (-0.00), greater than Endo International plc (-0.15), greater than Clarus Therapeutics Holdings, Inc. (-0.02), greater than Propanc Biopharma, Inc. (-0.11), less than Nexeon MedSystems Inc. (-0.00), less than Health-Chem Corporation (-0.00), less than Invitae Corporation (-0.00), greater than Aleafia Health Inc. (-0.18), less than Humanigen, Inc. (-0.00), greater than TRACON Pharmaceuticals, Inc. (-0.01),

Build a custom stock screener for Generex Biotechnology Corporation (GNBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Generex Biotechnology Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Generex Biotechnology Corporation (GNBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Generex Biotechnology Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.